Name | JC2-11 |
---|
Description | JC2-11 is an inhibitor of inflammatory corpuscles. JC2-11 reduces the secretion of caspase-1 (p20), the cleavage of gasdermin D (GSDMD), and the releases of IL-1β and lactate dehydrogenases (LDH) in inflammatory bodies. JC2-11 inhibits the activation of inflammatory bodies by destroying the production of reactive oxygen species and the activity of caspase-1[1]. |
---|---|
Related Catalog | |
Target |
NLRP3 inflammasome |
In Vivo | JC2-11 (250 μg/鼠;腹腔注射;单剂量) 显著抑制了 C57BL/6 小鼠模型中非典型 (NC) 炎症小体中 caspase-1 (p20) 和 IL-1β 的释放,弱化了 NC 炎症小体的激活[1]。 Animal Model: C57BL/6 mice (8 weeks, female)[1]. Dosage: 250 μg/mouse. Administration: Intraperitoneal injection; single dose. Result: Exhibited inhibitory effect on NC inflammatory body. |
References |
Molecular Formula | C17H15FO4 |
---|---|
Molecular Weight | 302.30 |